Isolation, Characterization, and cDNA Cloning of Chicken Turpentine-induced Protein, a New Member of the Scavenger Receptor Cysteine-rich (SRCR) Family of Proteins*

Ken Iwasaki, Masami MorimatsuDagger , Osamu Inanami§, Eiji Uchida, Bunei SyutoDagger , Mikinori Kuwabara§, and Masayoshi Niiyama

From the Department of Veterinary Internal Medicine II, School of Veterinary Medicine, Rakuno Gakuen University, Hokkaido 069-8501, Japan, the Dagger  Department of Veterinary Physiology, Faculty of Agriculture, Iwate University, Iwate 020-8550, Japan, and the § Department of Environmental Veterinary Medicine, Graduate School of Veterinary Medicine, Hokkaido University, Hokkaido 060-0818, Japan

Received for publication, December 26, 2000


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Acute-phase serum proteins were induced by administrating a chicken with turpentine oil. One of these proteins was a new protein that appeared in front of albumin in polyacrylamide disc gel electrophoresis using a 4.5-16% gel. To purify this protein, turpentine-administrated chicken serum was fractionated by ammonium sulfate precipitation at 50% saturation, and the supernatant fraction was chromatographed on a DEAE-Toyopearl 650S column. The purified protein is a mannose-glycoprotein, and its N-terminal sequence, determined by the Edoman method, is not homologous from that of other reported acute-phase proteins. An analysis of physiological function with two different test systems, chemiluminescence measurement and electron spin resonance spectroscopy, showed that the purified protein has antioxidant activity and inhibits superoxide (O&cjs1138;2) mediated by activation of the receptor. In support of these results, the complete amino acid sequence of 18-B is homologous to the scavenger receptor cysteine-rich (SRCR) family of proteins that participate in the regulation of leukocyte function. 18-B is composed of four SRCR domains, which is different from the previously characterized SRCR family of proteins such as Spalpha , CD6, and CD163. These findings indicate that turpentine-induced 18-B, a new member of scavenger receptor cysteine-rich family, may be implicated in regulation of cell function in a manner of inhibition of the overproduction of the reactive oxygen species.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Several acute-phase proteins in serum, such as C-reactive protein, hemopexin, fibrin, fibrinogen, transferrin, alpha 1-acid glycoprotein, and alpha 2-macroglobulin, have been reported in chicken (1-7). These proteins are present in normal serum, but their levels increase in inflammatory diseases. We have been searching for new marker proteins to improve the diagnosis for the acute phase of chicken. Turpentine enhances the synthesis of acute-phase proteins and has been used as an inducer of acute inflammation (8, 9).

Tohjo et al. (10) described two proteins, named 18-B and 18-C, that appeared in abundance after administration of turpentine. These proteins migrated in front of albumin in 4.5-16% polyacrylamide disc gel electrophoresis (PAGE).1 Since 18-B was not detected in the serum of healthy chickens, the protein was considered to be a new acute-phase protein. Tohjo et al. (10) did not further characterize 18-B.

On the other hand, Urban et al. (11) reported that a new acute-phase alpha -1 protein in rat was induced by turpentine administration and that its molecular mass based on SDS-PAGE was 68 kDa. 18-B in chicken is similar in electrophoretic characteristics and molecular size to Urban's protein in rat, but it is not clear whether both these proteins are identical or not.

In this study, we attempted to identify a new acute-phase protein in chicken serum to establish a new marker for acute-phase inflammation. Thus, we purified a turpentine-induced protein from chicken serum and compared its molecular properties with those of the rat protein. In addition, we report the physiological function, cDNA cloning, and characteristics of 18-B.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Chicken Serum-- An adult female Leghorn chicken was intramuscularly administrated with turpentine (3 ml/kg of body weight) and bled 48 h later. Serum was prepared and was stored at -20 °C before use.

Isolation Procedure of 18-B-- Saturated ammonium sulfate solution was added to the serum to 50% saturation, and the mixture was allowed to stand for 1 h at room temperature. A precipitate formed and was removed by centrifugation at 10,000 × g for 30 min at 10 °C. The supernatant was dialyzed against 1,000 volumes of borax-phosphate buffer (20 mM Na2B4O7·10H2O and 60 mM NaH2PO4·2H20, pH 8.1) overnight at 4 °C. The dialyzed sample was applied to a DEAE-Toyopearl 650S column (0.8 × 25 cm, Tosoh Co., Tokyo, Japan) equilibrated with the same buffer. Proteins were eluted from the column by the linear gradient method with 0-0.5 M NaCl in borax-phosphate buffer at a flow rate of 1 ml/min. The eluate was monitored at 280 nm. The fraction corresponding to a peak that was not observed in the serum of healthy chickens was collected. The purified protein was identified as 18-B by its mobility in the gradient gel electrophoresis (12).

Chemical Analysis-- Protein concentration was determined by the method of Lowry et al. (13) with BSA as the standard protein. The protein concentration in the column effluent was monitored by an UV monitor at a wavelength of 280 nm. Total carbohydrate content was determined by the phenol-sulfuric acid method with glucose as the standard (14). Sugar chains were analyzed using ConA, WGA, UEA-I, SBA, DBA, RCA-I, and PNA (Lectin Kit I, Vector Laboratories, Inc., Burlingame, CA).

Electrophoresis-- SDS-PAGE was carried out by the method of Laemmli (15) using myosin, beta -galactosidase, phosphorylase, BSA, ovalbumin, and carbonic anhydrase as standards. Disc electrophoresis was done according to the method of Syuto et al. (12). Protein bands were stained with Coomassie Brilliant Blue R-250, and carbohydrate was stained with PAS reagent (16).

Immunological Assay-- Gel double diffusion tests to assay the purity and antigenicity were done in 1% agarose in phosphate-buffered saline. Immunoblotting was performed by Towbin's method (17). A rabbit anti-chicken whole serum antibody and a rabbit anti-chicken albumin antibody were purchased from ICN Pharmaceuticals, Inc. (Aurora, OH). A goat anti-rabbit IgG labeled with horseradish peroxidase was obtained from Bio-Rad. A TMB Membrane Peroxidase Substrate System (Kirkegaard & Perry Laboratories Inc., Gaithersburg, MD) was used to detect the protein bands.

N-terminal Sequence Analysis-- The protein 18-B was blotted to a polyvinylidene difluoride membrane (Immobilon Transfer Membranes, Nihon Millipore Ltd., Tokyo, Japan) after SDS-PAGE on a 7.5% gel. The N-terminal amino acid sequence was determined by Edoman method with a model 477A protein sequencer on-line with a model 120A phenylthiohydantoin-derivative analyzer (PerkinElmer Life Sciences).

Preparations of Chicken Heterophils-- Heterophils were isolated by means of a discontinuous gradient of 18 and 24% Ficoll (Ficoll 400, Amersham Pharmacia Biotech AB, Uppsala, Sweden) according to the established method (18). The isolated cells were suspended in Ca2+/Mg2+-free HBSS (Life Technologies, Inc.). Cell viability was always more than 95% by a trypan blue exclusion test.

Preparation of Stimulants-- All the chemicals used below were purchased from Sigma. PMA and luminol were dissolved in dimethyl sulfoxide (Me2SO) at a stock concentration of 1 mg/ml and 100 mM, respectively. The final concentration of PMA was 1 µg/ml. The preparation of sOZ was done by treating zymosan A from Saccharomyces cerevisiae with fresh, normal chicken serum at a concentration of 0.01 mg/ml for 60 min at 37 °C. The final concentration of sOZ was 1 mg/ml.

Chemiluminescence Assay-- Superoxide (O&cjs1138;2) production from heterophils was measured by chemiluminescence with luminol. Cells (7.7 × 106 cells) were suspended in 1 ml of Ca2+/Mg2+-free HBSS containing 10 µM luminol, 50 µg/ml of horseradish peroxidase, 0.5 mM CaCl2, and 1 mM MgCl2. The cell suspension was allocated to each well of a 96-well microplate (315 µl/well) and preincubated for 5 min at 42 °C without and with 2, 3.5, and 5 µg of 18-B, or Cu/Zn-SOD (40 units/ml). The cells were then activated by adding 35 µl of PMA (10 µg/ml) or sOZ (10 mg/ml), and chemiluminescence from each well was immediately measured with a luminometer (Luminescencer-JNR, Atto Co., Tokyo, Japan) for 0.5 s at 42 °C.

ESR Spectroscopy-- Spin-trapping for oxygen free radicals from stimulated heterophils was performed by using DEPMPO (Oxis International Inc., Portland, OR). Cells (5 × 10 6 cells) were suspended in 216 µl of Ca2+/Mg2+-free HBSS containing 10 mM DEPMPO, 1 mM CaCl2, and 2 mM MgCl2 without or with 3.5 µg of 18-B, or Cu/Zn-SOD (40 units/ml). After cells were stimulated by addition of 24 µl of PMA (10 µg/ml) or sOZ (10 mg/ml), the reaction mixture was immediately transferred into quartz ESR flat cells (LLC-04B, Labotec Co., Tokyo, Japan). Then ESR spectra were recorded at room temperature (24 °C) with an X-band ESR spectrometer (RE-1X, JEOL Co., Tokyo, Japan). The interval from the end of incubation to the start of ESR measurements was 1 min. ESR settings were as follows: modulation frequency, 100 kHz; modulation amplitude, 0.1 millitesla; scanning field, 334.6 ± 15 mT; receiver gain, 5 × 103 for sOZ or 2.5 × 10 3 for PMA; time constant, 0.3 s; sweep time, 8 min; microwave power, 12 milliwatts; microwave frequency, 9.415 GHz.

RNA Isolation, cDNA Synthesis, and PCR Amplification-- Total RNA was isolated from chicken tissues with TriZOL reagent (Life Technologies, Inc.) according to the manufacturer's instructions. First strand cDNA was synthesized utilizing dT18-tailed oligonucleotide primer (KAUAP-18T, 5'-GACGACAAGGGGCCACGCG-18 dTTP-3') using Superscript II reverse transcriptase (Life Technologies, Inc.). The cDNA was added to a solution of 0.5 µM each forward and reverse primers derived from N-terminal amino acid sequences determined by Edoman method, and PCR was performed with Taq DNA polymerase (Takara, Kyoto, Japan).

DNA Sequencing-- To determine the sequence of the amplified products, PCR products were subcloned into the pGEM-T easy vector (Promega Co., Madison, WI). DNA sequencing was performed on at least three independent PCR products in both directions by the dideoxy-chain termination technique using the Big Dye Terminator Cycle Sequencing Ready Reaction Kit (PerkinElmer Life Sciences).

RACE-- 3'-RACE was carried out with primer P1 (5'-CCAGTACAGCTGAAGTTCGC-3') and adapter primer KAUAP. For further specification, a nested PCR was carried out with primer P2 (5'-GTACAGCTGAAGTTCGCCTG-3') and primer AUAP (5'-GGCCACGCGTCGACTAGTAC-3') using the previous PCR product as a template. From the obtained 3'-cDNA sequence, two gene-specific reverse primers, P3 (5'-GGACCACCTACCAGGTTTGT-3') and P4 (5'-AAGCGGACCACCTACCAGGT-3'), were designed for 5'-RACE. 5'-Reverse transcription was carried out with the outer primer P4 followed by RNase H treatment. The first strand cDNA was tailed at the 3'-end by terminal deoxynucleotidyl transferase (Life Technologies, Inc.) with dCTP and then subjected to PCR. The second strand cDNA was synthesized with primer KAUAP-GI (5'-KAUAP-TCGACTAGTACGGGIIGGGIIGGGIIG-3'). PCR amplification was carried out with primer P4 and KAUAP. Nested PCR was carried out using the primer P3 and AUAP, and the PCR products were subcloned and sequenced as described above.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Identification-- In the disc electrophoresis of chicken serum obtained after turpentine administration, two protein bands appeared in front of the albumin band (Fig. 1B). It was proved by 4.5-16% PAGE that the protein purified from the whole serum by salting-out and DEAE chromatography corresponds to the 18-B reported by Tohjo et al. (10). To determine whether the protein, 18-B, could be detected in normal chicken serum and whether it was antigenically different from chicken albumin, Western blotting was carried out. The 18-B was not detectable in the normal serum (Fig. 2B, lane 1), but the purified materials positively reacted with rabbit anti-chicken whole serum (Fig. 2B, lane 2). With anti-chicken albumin, only albumin, but not 18-B, was immunologically stained (Fig. 2C). These results indicate that 18-B exists at a very low concentration in normal chicken serum and is antigenically different from albumin.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 1.   Appearance of the new protein 18-B in acute-phase inflammation. Normal serum and serum from a turpentine-administrated chicken were electrophoresed on a 4.5-16% gradient gel. A, normal chicken serum. B, chicken serum obtained 48 h after intramuscular administration of turpentine. As shown in B, two peaks, 18-B and 18-C, appeared in front of 18-A (albumin).


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 2.   Identification of 18-B by immunoblotting with rabbit anti-chicken serum and rabbit anti-chicken albumin serum. A, protein staining with Coomassie Brilliant Blue R-250. Lane 1, albumin; lane 2, purified 18-B. B, immunoblotting with rabbit anti-chicken serum. Lane 1, normal chicken serum; lane 2, purified 18-B. C, immunoblotting with rabbit anti-chicken albumin serum. Lane 1, albumin; lane 2, purified 18-B. 18-B was not detected in the normal serum and was different from albumin in antigenicity.

Purification of 18-B-- The serum proteins in the turpentine-treated chicken were separated by DEAE chromatography (Fig. 3). When the column was eluted by the linear gradient method, 18-B was released in the high ionic strength phase as shown in Fig. 3. Finally, 0.4 mg of 18-B was obtained from 1 ml of the chicken acute-phase serum.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 3.   Elution profile of proteins on DEAE chromatography with a DEAE-Toyopearl-650S column. 18-B was eluted in the thirdpeak without contamination of other proteins.

Molecular Weight Determination-- The SDS-PAGE pattern indicated 18-B is a single peptide, and its molecular size is 54 or 66 kDa in the absence or presence of 2-mercaptoethanol, respectively (Fig. 4, lanes 2 and 3).


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 4.   Molecular size of 18-B. 18-B was electrophoresed by Laemmli's method (15) with a 7.5% gel under reduced and nonreduced conditions. Lane 1, marker protein (nonreduced); lane 2, purified 18-B (nonreduced); lane 3, purified 18-B (reduced); lane 4, marker proteins (reduced). The molecular size of 18-B is 54 or 66 kDa under nonreduced or reduced conditions, respectively.

Carbohydrate Constitution-- 18-B showed a positive reaction in PAS staining (Fig. 5A). A phenol-sulfuric acid assay indicated that 18-B contains ~28.6% (w/w) carbohydrate. 18-B was stained with ConA only, which is specific for terminal mannose residues, but it was not stained by WGA, UEA-I, SBA, DBA, RCA-I, or PNA (Fig. 5B). These results indicate that 18-B is a glycoprotein with mannose.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 5.   Carbohydrate analysis of 18-B. A, serum from a turpentine-administrated chicken and the purified 18-B were electrophoresed on a gradient gel. Lane 1, chicken serum stained with Coomassie Brilliant Blue R-250; lane 2, purified 18-B stained with PAS reagent. 18-B was stained with PAS reagent. B, 18-B was electrophoresed by Laemmli's method (15) and blotted to a polyvinylidene difluoride membrane, followed by staining with lectins. Lane 1, ConA; lane 2, WGA; lane 3, UEA-I; lane 4, SBA; lane 5, DBA; lane 6, RCA-I; lane 7, PNA. 18-B was stained with ConA only.

N-terminal Sequence-- The N-terminal amino acid sequence determined by Edoman method is shown in the gray highlighted areas of Fig. 8A. Primers for initial PCR were designed in this region.

Effects of 18-B on the Luminol-enhanced Chemiluminescence in PMA- and sOZ-stimulated Heterophils-- To study the involvement of 18-B in the functions of avian heterophils, we measured luminol-enhanced chemiluminescence from PMA-stimulated heterophils. PMA is known to directly stimulate PKC, to phosphorylate NADPH oxidase component such as p47phox and then activate NADPH oxidase to produce O&cjs1138;2 (19-21). When the cells were stimulated by PMA, the chemiluminescence rapidly increased in the first 10 min and then gradually decreased (closed circle of Fig. 6A). The PMA-induced chemiluminescence was inhibited by Cu/Zn-SOD (open square) but not by BSA (closed triangle). Thus, the PMA-induced chemiluminescence is due to O&cjs1138;2 production from the heterophils. When the cells were stimulated by PMA in the presence of 18-B, a small reduction of the chemiluminescence was observed. About 70-80% of the control peak counts was preserved, even in the presence of 18-B. Next, to investigate receptor-mediated O&cjs1138;2 production from the heterophils (22), sOZ was employed. The chemiluminescence evoked by sOZ (the control) was relatively low, but the kinetics of the increase of the chemiluminescence was similar to that in PMA stimulation (closed circles of Fig. 6B). The treatment of 18-B induced a dose-dependent decrease in sOZ-evoked chemiluminescence of heterophils (Fig. 6B). In contrast to PMA stimulation, the inhibition of the chemiluminescence of sOZ-stimulated cells by 18-B was significantly greater than that of PMA-stimulated cells. For example, in the presence of the same concentration of 18-B (5 µg/ml), the chemiluminescence peaks evoked by sOZ and PMA were 70 and 25% of the control values, respectively.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 6.   Effects of 18-B on the time course of chemiluminescence after stimulation to heterophils. Heterophils were incubated with different concentrations of 18-B, BSA or Cu/Zn-SOD for 5 min at 42 °C and then stimulated with PMA (A) and sOZ (B). Control response without an additive protein (closed circle); BSA, 3.5 µg/ml (closed triangle); Cu/Zn-SOD, 40 units/ml (open square). Each concentration of 18-B is as follows: 2 (open triangle), 3.5 (open circle), and 5 µg/ml (closed square). When cells were stimulated by PMA in the presence of 18-B, a small reduction of the chemiluminescence was observed. In contrast to PMA stimulation, the inhibition of the chemiluminescence of sOZ-stimulated cells by 18-B was significantly greater than that of PMA-stimulated cells.

Spin-trapping Detection of the Oxygen Radicals in PMA- and sOZ-stimulated Heterophils and the Effects of 18-B on the O&cjs1138;2 Production-- In preliminary experiments, we tried ESR spin-trapping using DMPO, which is known to be useful for detecting oxygen radicals in phagocytes (23, 24). These experiments were unsuccessful, possibly because the amount of O&cjs1138;2 produced from heterophils was quite low and because the DMPO spin-adducts was unstable (having half-lives of only a few minutes). Therefore, in this experiment, we used a new spin trap, the beta -phosphorylated nitrone DEPMPO. DEPMPO is much more stable than the DMPO adduct, having a 15-fold longer half-life. Fig. 7B shows the ESR signals when the heterophils were stimulated for 20 min by PMA in the presence of DEPMPO. Similarly, Fig. 7E shows the ESR signals when the heterophils were stimulated for 40 min by sOZ. These ESR signals were quite similar to those reported by Chamulitrat (25) and consisted of two signals due to DEPMPO-OOH and DEPMPO-OH. Both signals were completely inhibited by the presence of Cu/Zn-SOD. These results indicated that the DEPMPO-OOH and DEPMPO-OH adducts were produced by O&cjs1138;2 in PMA- and sOZ-stimulated heterophils. The components indicated by the asterisk and open circle were chosen for comparison, because the component due to DEPMPO-OOH (asterisk) did not overlap with that of DEPMPO-OH (open circle). Treatment of sOZ-stimulated heterophils with 18-B completely inhibited production of DEPMPO-OOH (asterisk in Fig. 7, E and F), although the reduction of PMA-induced DEPMPO-OOH by 18-B was small (asterisk in Fig. 7, B and C).


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 7.   ESR spectra from heterophils stimulated with PMA and sOZ. A, unstimulated control; ESR spectrum obtained after a solution containing cells and DEPMPO were incubated for 20 min. ESR spectra obtained at 20 min after cells, PMA, and DEPMPO were incubated without (B) and with 18-B (C) or Cu/Zn-SOD (D) are shown. ESR spectra obtained at 40 min after cells, sOZ, and DEPMPO were incubated without (E) and with 18-B (F) or Cu/Zn-SOD (G) are shown. Asterisk indicates the component due to DEPMPO-OOH, and open circle indicates the component due to DEPMPO-OH.

cDNA Cloning of 18-B-- We obtained the cDNA sequence of 18-B from a combination of PCR products as described under "Experimental Procedures" (Fig. 8A). The 1,410-bp open reading frame was followed by a 244-bp 3'-untranslated region. A potential polyadenylation signal was located 16 bp upstream of the poly(A) tail. The open reading frame encoded a protein with 470 deduced amino acids. There are two potential sites for N-linked glycosylation. The N-terminal region of deduced protein had the features of a secreted protein, which contained 20 hydrophobic amino acids. This hydrophobic peptide was followed by four cysteine-rich domains, each ~100 amino acids in length. These domains are significantly homologous to the cysteine-rich domains found in the SRCR group B family of proteins (Fig. 8B).


View larger version (95K):
[in this window]
[in a new window]
 
Fig. 8.   A, deduced amino acid sequence of 18-B cDNA. Putative signal peptide is double underlined. SRCR domains are underlined. Potential N-glycosylation site is bold. Polyadenylation site is italic. The N-terminal sequence determined previously by Edoman method is indicated by the gray highlighted areas. B, comparison of the domain structure of SRCR family proteins. Gray highlighted areas are regions 15 out of 19 amino acids are homologous. C, domain organization of 18-B, Spalpha , CD6, and CD163. TM, transmembrane; CT, cytoplasmic region.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In this study, 18-B was purified by salting-out and DEAE chromatography, finally yielding 0.4 mg of 18-B from 1 ml of the chicken acute-phase serum. This protein corresponds to 18-B reported by Tohjo et al. (10) and was first isolated in the present study. This protein is a single peptide with a molecular mass of 54 kDa.

Several chicken serum proteins, such as C-reactive protein, hemopexin, fibrin, fibrinogen, transferrin, alpha 1-acid glycoprotein, and alpha 2-macroglobulin, are shown to increase with increasing degree of inflammation (1-7). In addition, haptoglobin (9), transferrin (10), and alpha 1-acid glycoprotein (6) are shown to be elevated in chicken by administration of turpentine. However, none of these proteins had all the molecular properties of 18-B (molecular size, N-terminal sequence, carbohydrate composition, and antigenicity).

Urban et al. (11) reported a novel turpentine-induced glycoprotein with a single peptide chain in rat. This protein has a molecular mass of 56 kDa and a pI value of 4.7. These properties are similar to those of 18-B, but the N-terminal amino acid sequences of these two proteins are not homologous. These results suggest that 18-B is a new turpentine-induced protein of chicken.

To further understand the function of 18-B, the complete amino acid sequence was determined by cDNA cloning. The deduced amino acid sequence of 18-B has four repeated sequences. A search of all sequences in the GenBankTM data base was carried out to identify similar sequences, which resulted in homology with members of the SRCR family of proteins, such as hensin, macrophage scavenger receptor, WC1, CRP-ductin, ebnerin, CD163, Spalpha , CD5, and CD6. There are two types of SRCR family: SRCR group A domains contain six cysteine residues and are encoded by two exons, which include macrophage scavenger receptor and related proteins (26), etc. SRCR group B domains contain eight cysteine residues and are encoded by a single exon, which include leukocyte antigens CD5, CD6, CD163 (M130), WC1, and Spalpha , etc. (27-31). Each of the cysteine-rich domains of 18-B shares high degrees of sequence homology with that of SRCR group B family, in particular conserved sequence elements, including eight cysteine residues. These indicate that 18-B belongs to the SRCR group B family. The domain organization of 18-B is similar to, but different from, those of the previously reported proteins. Because 18-B is composed exclusively of SRCR domains, it can be distinguished from multidomain proteins that have both CUB (C1r/C1s Uegf Bmp 1) and ZP (zona pellucida) domains besides SRCR domain, such as hensin, CRP-ductin, and ebnerin (32-34). Furthermore, 18-B has neither transmembrane nor cytoplasmic domain, which indicates that 18-B is different from membrane proteins, such as CD5, CD6, and CD163 (27, 35, 29). Secreted protein, Spalpha , is the only protein that has such a simple domain organization, which is composed of SRCR domain only (31). However, comparison of 18-B with Spalpha revealed two major differences: the primary structure of 18-B is longer by 123 residues than that of Spalpha , and 18-B has four domains, whereas Spalpha has three SRCR domains. On the basis of these findings, we propose that 18-B is a new member of the SRCR group B family of proteins.

Leukocyte function is regulated by a discrete number of cell surface and secreted antigens that govern leukocyte activation, proliferation, survival, cell adhesion and migration, and effector function. Among the proteins that have been shown to regulate leukocyte function are members of the SRCR family (36-39). The results of the chemiluminescence measurement and ESR spectroscopy proved 18-B to be an antioxidant. The suppressive effect of 18-B on the O&cjs1138;2 production of heterophils is stronger in receptor-mediated response than of PKC-mediated response. This result was consistent in both chemiluminescence and ESR analysis, which indicate that 18-B inhibits O&cjs1138;2 mostly by activation of receptor and not by direct activation of PKC.

The function of members of the SRCR group B family is not defined conclusively and fully understood yet. WC1 is involved in gamma delta T cell regulation (30). CD5 and CD6 modulate T cell activation. Spalpha is thought to regulate monocyte function (31). These proteins obviously exert their functions after binding to a specific ligand: CD5 binds to CD72 (40), CD6 to ALCAM (39). No ligand has been defined yet for 18-B and the related CD163, WC1, and Spalpha . However, our results showing that 18-B inhibits O&cjs1138;2 mostly by activation of receptor suggest that there may be a 18-B-binding protein on heterophils, and 18-B may regulate heterophil function in a manner of inhibition of the overproduction of the reactive oxygen species.

In conclusion, our studies demonstrate that turpentine-induced 18-B is a new member of SRCR family of proteins, which may be implicated in regulation of cell function.

    FOOTNOTES

* This work was supported in part by Grant-in-aid 1999-1 to Cooperative Research from Rakuno Gakuen University, Dairy Science Institute.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence reported in this paper has been submitted to the DDBJ/GenBankTM/EBI Data Bank with accession number AB051832.

To whom correspondence should be addressed. Tel.: 81-11-388-4757; Fax: 81-11-386-9629; E-mail: niiyamam@rakuno.ac.jp.

Published, JBC Papers in Press, January 2, 2001, DOI 10.1074/jbc.M011713200

    ABBREVIATIONS

The abbreviations used are: PAGE, polyacrylamide disc gel electrophoresis; BSA, bovine serum albumin; ConA, concanavalin A; WGA, wheat germ agglutinin; UEA-I, ulex europeus agglutinin I; SBA, soybean agglutinin; DBA, dolichos biflorus agglutinin; RCA-I, ricinus communis agglutinin I; PNA, peanut agglutinin; PAS, periodic acid-Schiff; HBSS, Hanks' balanced salt solution; PMA, phorbol 12-myristate 13-acetate; sOZ, serum-opsonized zymosan; O&cjs1138;2, superoxide; Cu/Zn-SOD, copper- and zinc-containing superoxide dismutase; ESR, electron spin resonance; DEPMPO, 5-(diethoxyphosphoryl)-5-methyl-1-pyrroline N-oxide; PKC, protein kinase C; DMPO, 5,5-dimethyl-1-pyrroline N-oxide; PCR, polymerase chain reaction; RACE, rapid amplification of cDNA end; bp, base pair(s); SRCR, scavenger receptor cysteine-rich.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Patterson, L. T., and Mora, E. C. (1965) Tex. Rep. Biol. Med. 23, 600-606[Medline] [Order article via Infotrieve]
2. Grieninger, G., Liang, T. J., Beuving, G., Goldfarb, V., Metcalfe, S. A., and Muller-Eberhard, U. (1986) J. Biol. Chem. 261, 15719-15724[Abstract/Free Full Text]
3. Amrani, D. L., Mauzy-Melitz, D., and Mosesson, M. W. (1986) Biochem. J. 238, 365-371[Medline] [Order article via Infotrieve]
4. Grieninger, G., Oddoux, C., Diamond, L., Weissbach, L., and Plant, P. W. (1989) Ann. N. Y. Acad. Sci. 557, 257-270[Medline] [Order article via Infotrieve]
5. Hallquist, N. A., and Klasing, K. C. (1994) Comp. Biochem. Physiol. Biochem. Mol. Biol. 108, 375-384[Medline] [Order article via Infotrieve]
6. Delers, F., Domingo, M., and Engler, R. (1983) Comp. Biochem. Physiol. 74, 619-622
7. Klasing, K. C. (1991) Poult. Sci. 70, 1176-1186[Medline] [Order article via Infotrieve]
8. Sinha, B. K., Vegad, J. L., and Awadhiya, R. P. (1987) Res. Vet. Sci. 42, 365-372[Medline] [Order article via Infotrieve]
9. Jain, N. K., Vegad, J. L., and Awadhiya, R. P. (1982) Vet. Rec. 110, 421-422[Medline] [Order article via Infotrieve]
10. Tohjo, H., Miyoshi, F., Uchida, E., Niiyama, M., and Syuto, B. (1995) Poult. Sci. 74, 648-655[Medline] [Order article via Infotrieve]
11. Urban, J., Chan, D., and Schreiber, G. (1979) J. Biol. Chem. 254, 10565-10568[Abstract]
12. Syuto, B., Miyake, Y., and Kubo, S. (1981) Jpn. J. Vet. Sci. 43, 71-77
13. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) J. Biol. Chem. 193, 265-275[Free Full Text]
14. Dubois, M., Gilles, K. A., Hamilton, J. K., Rebers, P. A., and Smith, F. (1956) Anal. Chem. 28, 350-356
15. Laemmli, U. K. (1970) Nature 227, 680-685[Medline] [Order article via Infotrieve]
16. Felgenhauer, K. (1970) Clin. Chim. Acta 27, 305-312[Medline] [Order article via Infotrieve]
17. Towbin, H., Staehelin, T., and Gordon, J. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 4350-4354[Abstract]
18. Thies, E. S., Nelson, R. D., and Maheswaran, S. K. (1983) Am. J. Vet. Res. 44, 288-292[Medline] [Order article via Infotrieve]
19. Babior, B. M., Kipnes, R. S., and Curnutte, J. T. (1973) J. Clin. Invest. 52, 741-744[Medline] [Order article via Infotrieve]
20. Inanami, O., Johnson, J. L., McAdara, J. K., Benna, J. E., Faust, L. P., Newburger, P. E., and Babior, B. M. (1998) J. Biol. Chem. 273, 9539-9543[Abstract/Free Full Text]
21. Inanami, O., Johnson, J. L., and Babior, B. M. (1998) Arch. Biochem. Biophys. 350, 36-40[CrossRef][Medline] [Order article via Infotrieve]
22. Yamamori, T., Inanami, O., Nagahata, H., Cui, Y., and Kuwabara, M. (2000) FEBS Lett. 467, 253-258[CrossRef][Medline] [Order article via Infotrieve]
23. Britigan, B. E., Cohen, M. S., and Rosen, G. M. (1987) J. Leukoc. Biol. 41, 349-362[Abstract]
24. Britigan, B. E., Rosen, G. M., Chai, Y., and Cohen, M. S. (1986) J. Biol. Chem. 261, 4426-4431[Abstract/Free Full Text]
25. Chamulitrat, W. (1999) Free Radic. Biol. Med. 27, 411-421[CrossRef][Medline] [Order article via Infotrieve]
26. Kodama, T., Freeman, M., Rohrer, L., Zabrecky, J., Matsudaira, P., and Krieger, M. (1990) Nature 343, 531-535[CrossRef][Medline] [Order article via Infotrieve]
27. Jones, N. H., Clabby, M. L., Dialynas, D. P., Huang, H. J., Herzenberg, L. A., and Strominger, J. L. (1986) Nature 323, 346-349[Medline] [Order article via Infotrieve]
28. Huang, H. J., Jones, N. H., Strominger, J. L., and Herzenberg, L. A. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 204-208[Abstract]
29. Law, S. K., Micklem, K. J., Shaw, J. M., Zhang, X. P., Dong, Y., Willis, A. C., and Mason, D. Y. (1993) Eur. J. Immunol. 23, 2320-2325[Medline] [Order article via Infotrieve]
30. Wijngaard, P. L., Metzelaar, M. J., MacHugh, N. D., Morrison, W. I., and Clevers, H. C. (1992) J. Immunol. 149, 3273-3277[Abstract/Free Full Text]
31. Gebe, J. A., Kiener, P. A., Ring, H. Z., Li, X., Francke, U., and Aruffo, A. (1997) J. Biol. Chem. 272, 6151-6158[Abstract/Free Full Text]
32. Takito, J., Yan, L., Ma, J., Hikita, C., Vijayakumar, S., Warburton, D., and Al-Awqati, Q. (1999) Am. J. Physiol. 277, F277-F289[Abstract/Free Full Text]
33. Cheng, H., Bjerknes, M., and Chen, H. (1996) Anat. Rec. 244, 327-343[CrossRef][Medline] [Order article via Infotrieve]
34. Li, X. J., and Snyder, S. H. (1995) J. Biol. Chem. 270, 17674-17679[Abstract/Free Full Text]
35. Aruffo, A., Melnick, M. B., Linsley, P. S., and Seed, B. (1991) J. Exp. Med. 174, 949-952[Abstract]
36. Krieger, M. (1997) Curr. Opin. Lipidol. 8, 275-280[Medline] [Order article via Infotrieve]
37. Aruffo, A., Bowen, M. A., Patel, D. D., Haynes, B. F., Starling, G. C., Gebe, J. A., and Bajorath, J. (1997) Immunol. Today 18, 498-504[CrossRef][Medline] [Order article via Infotrieve]
38. Vijayakumar, S., Takito, J., Hikita, C., and Al-Awqati, Q. (1999) J. Cell Biol. 144, 1057-1067[Abstract/Free Full Text]
39. Whitney, G. S., Starling, G. C., Bowen, M. A., Modrell, B., Siadak, A. W., and Aruffo, A. (1995) J. Biol. Chem. 270, 18187-18190[Abstract/Free Full Text]
40. van de Velde, H., von Hoegen, I., Luo, W., Parnes, J. R., and Thielemans, K. (1991) Nature 351, 662-665[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.